This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Peregrine Pharmaceuticals Inc (PPHM)

NASDAQ: Health Care

Company Cash Flow
Apr 2015 Apr 2014 Apr 2013 Apr 2012
Cash Flow From Operating Activities
Net Income (Loss) -50.36M -35.36M -29.78M -42.12M
Operating Gains/Losses 2.00K 4.00K 1.70M 2.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -2.48M 330.00K 691.00K -871.00K
(Increase) Decrease in Inventories -1.82M -1.19M -728.00K 1.67M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 3.28M -391.00K -691.00K -601.00K
(Decrease) Increase In Other Current Liabilities 194.00K 995.00K -43.00K 3.88M
(Increase) Decrease In Other Working Capital 7.36M 878.00K 3.31M -1.71M
Other Non-Cash Items 6.70M 6.21M 3.44M 2.77M
Net Cash From Continuing Operations -36.02M -28.25M -20.93M -35.88M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -36.02M -28.25M -20.93M -35.88M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -9.05M -755.00K -853.00K -1.55M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 598.00K -1.77M 102.00K 383.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -8.45M -2.52M -751.00K -1.17M
Issuance of Debt 0.00 0.00 14.75M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 38.34M 73.33M 40.15M 33.42M
Repayment of Long-Term Debt -13.00K -32.00K -15.08M -1.41M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends -3.35M -232.00K 0.00 0.00
Other Financing Charges, Net 0.00 0.00 -975.00K 0.00
Net Cash From Financing Activities 34.98M 73.06M 38.85M 32.01M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -9.49M 42.29M 17.17M -5.04M

PPHM Peregrine Pharmaceuticals Inc

Chart of PPHM

Analysts Ratings for PPHM

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

PPHM Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs